الإحصائيات الأساسية
| LEI | 529900UD7C9N3AQO1V88 |
| CIK | 1556609 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sihuan Pharmaceutical Holdings Group Ltd.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| November 22, 2019 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 15, 2019 JPMorgan Chase Bank, N. |
|
| November 22, 2019 |
EX-99.(E) 4 e618833ex99-e.htm Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6Pos (Knorr-Bremse AG 333-227925) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to desi |
|
| November 22, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or organization of Issuer) JPMorgan Chase Bank, N |
|
| November 22, 2019 |
Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N. |
|
| August 26, 2016 |
Unassociated Document Certification under Rule 466 The depositary, JPMorgan Chase Bank, N. |
|
| August 26, 2016 |
Sihuan Pharmaceutical Holdings POS 333-209261 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or o |
|
| August 26, 2016 |
Number Each American Depositary Share represents Forty Shares Unassociated Document Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N. |
|
| August 26, 2016 |
Number Each American Depositary Share represents Forty Shares Unassociated Document Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N. |
|
| August 26, 2016 |
Sihuan Pharmaceutical Holdings POS 333-209261 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or o |
|
| August 26, 2016 |
Unassociated Document Certification under Rule 466 The depositary, JPMorgan Chase Bank, N. |
|
| March 27, 2013 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 March 27, 2013 Deutsche Bank Trust Company Americas, as Depositary 60 Wall Street New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited shares of the foreign private issuer whose name appears on |
|
| March 27, 2013 |
Certification under Rule 466 The depositary, Deutsche Bank Trust Company Americas, represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Finmeccanica SpA 333-170944) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. |
|
| March 27, 2013 |
F-6EF 1 e610764f6ef-sph.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd. (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or organization of I |
|
| March 27, 2013 |
Number Each American Depositary Share represents Forty Shares Deutsche Bank Trust Company Americas American Depositary Receipt Evidencing American Depositary Shares For Ordinary Shares of Sihuan Pharmaceutical Holdings Group Ltd. |
|
| August 29, 2012 |
As filed with the Securities and Exchange Commission on August 29, 2012 Registration No. |
|
| August 29, 2012 |
Writer’s Direct Dial EXHIBIT 4 EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www. |
|
| August 29, 2012 |
EX-1 2 sihuanreceipt.htm FORM OF RECEIPT AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents Forty (40) Shares) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (INCORPORATED UNDER THE LAWS OF BERMUDA) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) th |
